NEW DELHI :
The Union executive has allowed the Serum Institute of India to export 50 lakh doses of COVID-19 vaccine Covishield beneath the UN-backed COVAX international vaccine programme to Nepal, Tajikistan and Mozambique, reliable resources stated on Sunday.
Along with those 3 international locations, the SII may even export Covishield to Bangladesh beneath COVAX, they stated.
The SII will begin Covid vaccine export beneath the COVAX programme from November 23 and Nepal will obtain the primary lot of Covishield on November 24.
The federal government, previous in October, had accepted the SII to export 10 lakh Covishield doses each and every to Nepal, Myanmar and Bangladesh beneath the ‘Vaccine Maitri’ programme.
In a up to date communique to the Union Well being Ministry, Prakash Kumar Singh, Director, Executive and Regulatory Affairs at Serum Institute of India (SII) is learnt to have knowledgeable that the Pune-based company has manufactured inventory of 24,89,15,000 doses of Covishield and that the inventory is expanding day-to-day.
By no means leave out a tale! Keep attached and knowledgeable with Mint.
our App Now!!